Franklyn Health is a small CRO from the UK and EU. Rob Bedford, CEO, was 7,000 miles from home at LSI Asia 2026 in Singapore.

For a long time our industry assumed Medtech innovation flowed from West to East. That assumption is well out of date. Some of the most ambitious device and diagnostics work we come across now is being built in Singapore, South Korea, Japan, China and across the wider region.

We work with innovators who want to bring their technology into Europe and the US. The clinical evidence that gets them through MDR, IVDR and FDA is what we do. LSI Asia was a great opportunity to learn, and to support innovators with their global market access ambitions.